Cardioprotective effect of beta-3 adrenergic receptor agonism: Role of neuronal nitric oxide synthase

Xiaolin Niu*, Vabren L. Watts, Oscar H. Cingolani, Vidhya Sivakumaran, Jordan S. Leyton-Mange, Carla LaShannon Ellis, Karen L. Miller, Konrad Vandegaer, Djahida Bedja, Kathleen L. Gabrielson, Nazareno Paolocci, David A. Kass, Lili A. Barouch

*Corresponding author for this work

Research output: Contribution to journalArticle

79 Scopus citations

Abstract

Objectives: The aim of this study was to determine whether activation of β3-adrenergic receptor (AR) and downstream signaling of nitric oxide synthase (NOS) isoforms protects the heart from failure and hypertrophy induced by pressure overload. Background: β3-AR and its downstream signaling pathways are recognized as novel modulators of heart function. Unlike β1- and β2-ARs, β3-ARs are stimulated at high catecholamine concentrations and induce negative inotropic effects, serving as a "brake" to protect the heart from catecholamine overstimulation. Methods: C57BL/6J and neuronal NOS (nNOS) knockout mice were assigned to receive transverse aortic constriction (TAC), BRL37344 (β3 agonist, BRL 0.1 mg/kg/h), or both. Results: Three weeks of BRL treatment in wild-type mice attenuated left ventricular dilation and systolic dysfunction, and partially reduced cardiac hypertrophy induced by TAC. This effect was associated with increased nitric oxide production and superoxide suppression. TAC decreased endothelial NOS (eNOS) dimerization, indicating eNOS uncoupling, which was not reversed by BRL treatment. However, nNOS protein expression was up-regulated 2-fold by BRL, and the suppressive effect of BRL on superoxide generation was abrogated by acute nNOS inhibition. Furthermore, BRL cardioprotective effects were actually detrimental in nNOS -/- mice. Conclusions: These results are the first to show in vivo cardioprotective effects of β3-AR-specific agonism in pressure overload hypertrophy and heart failure, and support nNOS as the primary downstream NOS isoform in maintaining NO and reactive oxygen species balance in the failing heart.

Original languageEnglish (US)
Pages (from-to)1979-1987
Number of pages9
JournalJournal of the American College of Cardiology
Volume59
Issue number22
DOIs
StatePublished - May 29 2012

Keywords

  • heart failure
  • hypertrophy
  • nitric oxide synthase
  • oxidative stress
  • β3-adrenergic receptor

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Cardioprotective effect of beta-3 adrenergic receptor agonism: Role of neuronal nitric oxide synthase'. Together they form a unique fingerprint.

  • Cite this

    Niu, X., Watts, V. L., Cingolani, O. H., Sivakumaran, V., Leyton-Mange, J. S., Ellis, C. L., Miller, K. L., Vandegaer, K., Bedja, D., Gabrielson, K. L., Paolocci, N., Kass, D. A., & Barouch, L. A. (2012). Cardioprotective effect of beta-3 adrenergic receptor agonism: Role of neuronal nitric oxide synthase. Journal of the American College of Cardiology, 59(22), 1979-1987. https://doi.org/10.1016/j.jacc.2011.12.046